Advice for patients

Motherisk (www.motherisk.org) (Includes online information, fact-sheets, and has a "warm-line" phone number for advice for patients and clinicians during normal business hours.)... 

Hartwell, D. and Henry, J., Dietary advice for patients undergoing coronary artery bypass surgery falling on deaf ears Int. J. Food Sci., 54, 37, 2003. 

AMH content is written after consideration of best available scientific evidence, the Product Information, standard international reference sources, and Australian evidence-based and consensus guidelines from government and nongovernment agencies. Information is concise and clinically relevant for Australian practice, providing comparisons between drugs and between drug classes, with a focus on comparative efficacy, safety, and cost. Key advice for patients about how to use medicines safely and effectively is included. 

D Incalci M, Steward WP, Gescher AJ (2007) Modulation of response to cancer chemotherapeutic agents by diet constituents is the available evidence sufficiently robust for rational advice for patients Cancer Treat Rev 33 223-229... 

This book, which incorporates materials written by some of the finest minds in pharmacy practice and education, can enable the reader to play a crucial role in improving the drug use process for patients, providers, payers, and society. The purpose of this book is to help hone your skills so you can make a real improvement in the therapies you provide to your patients. Current and future clinicians can rely on the information laid out here to enhance your knowledge and allow you to assist your patients with the sound advice that they expect you to provide. Use the text, case histories, and numerous examples detailed here to expand your therapeutic skills, and to help positively impact your patients in the years to come. 

Guidelines for the treatment of ischemic heart disease have become very sophisticated and even incorporate advice for the psychological treatment of the patient to improve outcome. They are very useful at the present day. However, in the acmal clinical... 

Some studies have added further interventions for patients receiving nicotine patches, including programmes on the internet. One large trial (Strecher et al. 2005) offered free web-based behavioural support to individuals who purchased a particular brand of patch, and found both general benefits, plus additional ones when the internet programme collected specific information from users and tailored advice to their needs. 

The author is deeply indebted to Professor Raymond Daudel for his kind hospitality during the summers of 1962 and 1963 at the Centre de Mficanique Ondulatoire Appliqu e (Paris 19, France) where the bulk of this study was carried out. He is especially grateful to Dr. Odilon Chalvet for invaluable advice and patient guidance throughout the course of this work, and would like to thank Dr. Joyce Kaufman and Professor Hans Jaffe for several stimulating discussions. 

Advice for treatment decisions based on specific genetic conditions were found in four Pis, namely that prolastin (a 1-proteinase inhibitor) is not indicated in patients with certain otl -antitrypsin deficiency phenotypes, trastuzumab indicated only in patients with overexpression of the HER2 protein, tretinoin, and imatinib are to be given only in patients with either a specific subtype of acute myelogenous leukemia or Philadelphia chromosome-positive chronic myeloid leukemia, respectively. 

Mr Jones is subsequently transferred to the cardiology ward where his continuing atrial fibrillation is later confirmed as persistent atrial fibrillation. As the ward clinical pharmacist, you are responsible for daily review of drug charts and advice to medical and nursing staff on all aspects of drug treatment for patients on the ward. 

It is imperative for patients to manage the side-effects of oral chemotherapy appropriately. This includes knowing when to stop taking the tablets should severe adverse effects occur. There are clear recommendations for stopping capecitabine should certain specific side-effects occur whilst taking the drug and contacting the treatment centre for further advice. These include ... 

The half-life has been shown to be prolonged in some single-dose studies, but no accumulation or hepatotoxicity has been shown after repeated dosing, therefore normal doses and frequency can be used. Further advice as for Patient 3 with compensated cirrhosis. 

Advice as for Patient 3, but may require reduced frequency of dosing. Strong opioids... 

Advice as for Patient 3, but greater care needs to be taken because increased accumulation is likely to occur as the metabolic capacity of the liver is affected in decompensated cirrhosis. Doses at the higher end of the range given are unlikely to be tolerated. 

USP DI Advice for the Patient, 16th Ed. United States Pharmacopeial Convention Rand McNally, Rockville, Maryland, 1996. 

A patient who refuses to comply with instructions for preparing the skin before a peel will not be naturally inclined to heed advice for care during or after the peel sessions either. It is always preferable not to peel a patient who is incapable of understanding or accepting these instructions. Testing patient compliance is all the more important since preparing the skin and keeping up cosmetic care afterwards affect the quality of the results. 

Treatment is prompt removal from exposure. Preservation of income is an important problem in many countries, and a disincentive for patients to comply with this advice. Appropriate pharmacotherapy is needed for residual symptoms, which may persist for many years, and often permanently. 

United States Pharmacopeial Convention Inc. USPDI Advice for the patient Drug Information in Lay Language, Vol. II, 19th ed. Taunton, MA, Rand-McNally 1999 612-616. 

---